Tectonic Therapeutic reported $-19.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD 6.11M 28.92M Mar/2025
Alnylam Pharmaceuticals USD 186.42M 64.66M Dec/2025
Celltrion KRW 331.35B 270.18B Sep/2025
Cspc Pharmaceutical CNY 963.54M 106.35M Sep/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Divis Laboratories Ltd INR 5.83B 1.06B Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
Ionis Pharmaceuticals USD -229M 100.39M Dec/2025
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Karyopharm Therapeutics USD -30.78M 1.29M Dec/2024
Knight Therapeutics CAD 85K 2.03M Sep/2024
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
MacroGenics USD 16.82M 53.07M Sep/2025
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -105K 409K Jun/2025
Neuren Pharmaceuticals AUD 7.52M 126.51M Jun/2025
Organigram Holdings CAD -37.96M 31.67M Sep/2025
Ovoca Bio EUR -5.65M 3.28M Jun/2022
Pfizer USD -1.65B 5.19B Dec/2025
Pharma Mar EUR -4.1M 27.47M Sep/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
Sanofi EUR -801M 3.6B Dec/2025
Sarepta Therapeutics USD -179.95M 376.84M Sep/2025
Sartorius EUR 43.8M 11.3M Sep/2025
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Takeda JPY 103.64B 115.44B Dec/2025
Tilray USD -44.93M 44.61M Sep/2025
Zz Pientze Pharmaceu CNY 687.04M 244.51M Sep/2025